Otto Scheiner
Otto Scheiner was born in 1944. He studied Biochemistry and Physics at the University of Vienna. After his thesis at the Department of General Biochemistry on "Enzymatic Phosphorylation of myo-Inositol and L-myo-Inositol-1-phosphate" and his graduation with a Ph. D. degree, he worked as a research assistant at the Department of General and Experimental Pathology (now Dept. of Pathophysiology) of the Univerity of Vienna Medical School.
He extended his scientific experience during a two years scientific fellowship at the Department of Medical Microbiology of the Johannes Gutenberg University, Mainz, Germany. Returning to the Department of General and Experimental Pathology, he became a senior research assistant and is now professor for general and experimental pathology and head of the Division of Applied Experimental Pathology.
The major fields of Professor Scheiner's research activities have been covering the areas of immunology and allergology. He published extensively on the characterization of plant allergens and the use of recombinant allergens for diagnostic and therapeutic purposes. In recent time, phage display technology was used in his labs for the characterization of the allergen-specific antibody response. The experience obtained by this work has recently lead to the extension of research activities into the characterization of tumor antigens and the generation of minotopes for tumor-inhibiting antibodies. This technology lays the basis of the MimVac® tumor vaccine developed by BioLife Science.